Solutions · Medical Communications
Your MLR-Approved Content. Every Format Prescribers Use.
Pharma and medical device teams invest significantly in approved clinical content. Conforma ensures it reaches HCPs in the formats they’ll actually engage with — and tells you which ones worked.
The MLR process exists because clinical and promotional communications carry real consequence. It also exists because HCPs engage differently — a cardiologist between rounds and a primary care physician at their desk don’t reach for the same format. Once your medical, legal, and regulatory teams have approved the content, Conforma ensures it reaches every prescriber in the format most likely to drive engagement — and that the governance obligation travels with it through every format it takes.
1
What your MLR team approved is exactly what every prescriber receives.
A cardiologist reviewing a new indication between rounds and a primary care physician scanning materials in a waiting room don’t engage with clinical content the same way. They need different formats — but they need the same approved information. Conforma transforms your MLR-cleared content into video, audio, infographic, and written summary — all from the same approved source, all delivered through a single HCP interface.
WHAT THIS GIVES YOU
- MLR-approved source preserved across all formats
- Required language and disclosures traceable back to the approved sourced in every format
- Total HCP format access counts captured as they happen
2
Format-level HCP access data. Not just open rates.
Most HCP marketing analytics confirm delivery. Conforma tells you how many times your HCPs opened the Multimedia Bar — visible live in the platform. Dwell time per format is coming within weeks. For omnichannel and digital excellence teams, that’s a different quality of signal. Deeper engagement data across a deployment is surfaced by Conforma, helping you understand which formats are actually driving meaningful engagement.
WHAT THIS GIVES YOU
- Dwell time per format
- Engagement data surfaced by Conforma for brand and medical affairs teams
- Total HCP format access counts — live in the platform
3
MLR approval is the starting line. Conforma protects everything after it.
Significant resources go into getting content through MLR. What happens to that investment after approval is where governance typically gets thin. Format variations drift from the approved source. Versions circulate past their approval window. Required language gets dropped in adaptation. Conforma closes that gap — every format is derived from the approved source, traceable back to it, and flagged if the source updates before continuing in distribution.
WHAT THIS GIVES YOU
- Approval routing by role
- Full audit trail by format and distribution event
- Source updates require a new project
Conforma works downstream of your MLR process — it doesn’t replace or replicate it. Conforma’s role begins when approval is confirmed: transforming the approved source into synchronized formats and maintaining its integrity throughout distribution. The audit trail supports MLR accountability without adding to the review burden.
A As a governed content delivery layer — not a replacement for your existing channels or platforms. Conforma addresses a specific gap: ensuring approved clinical and promotional content reaches HCPs in the formats most likely to drive engagement, with data on what actually worked. Integration pathways are scoped during the Guided Pilot.
Yes. Each brand or therapeutic area operates within its own governed environment — separate approved sources, separate approval routing, separate audit trails. Content from one brand does not interact with another. For pharma organizations managing multiple brands under shared medical affairs infrastructure, this separation is part of standard deployment.
Engagement data in Conforma is role-based and access-controlled. Your organization defines which roles can view which reporting layers. Data is not shared across organizations or used to train external models. Full data handling documentation is provided during pilot scoping — your legal and compliance teams will want to review it.
The original project is retired and a new project is started from the revised source. The updated content goes through the same editor review and format approval process before a new distribution package is released. For HCP-facing content where regulatory or clinical accuracy is non-negotiable, that means no updated version reaches prescribers without a completed approval. The original distribution record remains intact — the two projects are distinct and separately documented.
Conforma gives both teams a shared infrastructure — one approved source that marketing distributes in multiple formats, with an audit trail that medical affairs can point to. Format-level engagement data is accessible to both teams within role-based permissions. It doesn’t resolve organizational tensions, but it gives them a common factual record to work from.
Both — and the channel distinction matters less than the governance question it raises. Whether an MSL is sharing content in a one-on-one conversation or a digital campaign is distributing it across a prescriber segment, the governance obligation is the same. Conforma applies the same infrastructure to both contexts.
A structured 30–60 day evaluation built around one approved content program and a defined HCP audience segment. The pilot produces format-level engagement data, governance documentation your medical affairs and legal teams can review, and organizational intelligence about HCP format preferences in your specific therapeutic area.
Conforma does not provide medical, legal, or regulatory compliance advice. Pharma and medical device organizations are solely responsible for ensuring HCP-facing content meets applicable regulatory and promotional standards including MLR requirements.